Biofilm on Chest Drains After Thoracic Surgery: Clinical Impact and Antibiotic Resistance
Biofilm Formation on Thoracic Drains: Clinical Significance and Association With Antibiotic Resistance
1 other identifier
observational
180
1 country
1
Brief Summary
This prospective observational study aims to investigate the frequency and clinical significance of biofilm formation on thoracic chest drains used after thoracic surgery. Biofilms are structured bacterial communities that adhere to surfaces and can promote infection and antibiotic resistance. In this study, small samples from the tips of chest drains will be collected under sterile conditions at the time of drain removal and analyzed in the microbiology laboratory. The main objectives are to evaluate the relationship between the duration of chest drain placement and the presence of biofilm, and to identify the antibiotic resistance profiles of microorganisms isolated from these biofilms. Secondary outcomes include the association between biofilm formation, postoperative infections (such as empyema or wound infection), and the length of hospital stay. This study will be conducted at Ondokuz Mayıs University Faculty of Medicine, Department of Thoracic Surgery, in collaboration with the Department of Microbiology. The findings are expected to contribute to better understanding of optimal drain management and infection prevention strategies after thoracic surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2025
CompletedFirst Submitted
Initial submission to the registry
November 13, 2025
CompletedFirst Posted
Study publicly available on registry
November 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
ExpectedNovember 19, 2025
November 1, 2025
5 months
November 13, 2025
November 16, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Presence and Intensity of Biofilm Formation on Chest Drain Tips
Biofilm formation on the inner surface of chest drain tips will be evaluated using a microplate crystal violet staining method. The optical density (OD) at 492 nm will be measured, and biofilm intensity will be classified according to the Christensen and Chusri scale (non, weak, moderate, strong). The proportion of patients with biofilm-positive drain tips will be recorded and compared across drain duration groups.
At the time of chest drain removal (postoperative days 1-7)
Study Arms (3)
Group 1 -Short Drain Duration (≤2 Days)
Participants whose thoracic chest drains were removed within 2 days after surgery. Drain tip samples from these patients will be analyzed for biofilm formation and microbiological culture.
Group 2 - Moderate Drain Duration (3-4 Days)
Participants whose thoracic chest drains remained in place for 3 to 4 days postoperatively. Drain tips will be examined for biofilm presence and bacterial growth patterns.
Group 3 - Long Drain Duration (≥5 Days)
Participants with chest drains in place for 5 days or longer. Biofilm formation, bacterial species identification, and antibiotic resistance profiles will be evaluated.
Interventions
No active intervention; routine chest drain removal followed by microbiological and biofilm analysis of drain tip samples.
Eligibility Criteria
Adult patients (≥18 years old) who undergo elective thoracic surgery at Ondokuz Mayıs University Faculty of Medicine and require postoperative chest drain placement. Participants are prospectively enrolled and observed until drain removal. Drain tip samples are collected for microbiological and biofilm analysis.
You may qualify if:
- Age 18 years and older
- Undergoing elective thoracic surgery requiring chest drain placement
- Able and willing to provide written informed consent
You may not qualify if:
- Presence of active infection prior to surgery
- Emergency thoracic surgery
- Immunosuppressed patients (e.g., neutropenia, advanced malignancy, organ transplantation)
- Patients receiving systemic antibiotic therapy at the time of drain removal
- Drainage for empyema or pre-existing pleural infection
- Presence of extrathoracic infection focus
- Refusal or inability to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Caner İşevi, MDlead
Study Sites (1)
Ondokuz Mayis University Medical Faculty, Department of Thoracic Surgery
Samsun, Samsun, 55139, Turkey (Türkiye)
Biospecimen
Small sections of chest drain tips will be collected for microbiological culture and biofilm analysis. No genetic or DNA-based testing will be performed.
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 13, 2025
First Posted
November 14, 2025
Study Start
October 1, 2025
Primary Completion
March 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
November 19, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared because the dataset includes sensitive clinical and microbiological information collected from a single-center study. Data will be used only for the approved research protocol and analyzed in aggregate form to protect participant confidentiality in accordance with institutional and national data protection regulations.